Longeveron (LGVN) Operating Expenses (2020 - 2026)

Longeveron's (LGVN) quarterly Operating Expenses came in at $5.0 million in Q1 2026, down 7.64% year-on-year from $5.5 million in Q1 2025, and down 10.91% quarter-over-quarter from $5.7 million in Q4 2025.

Longeveron (LGVN) Operating Expenses (2020 - 2026) Analysis & Trends

Longeveron's Operating Expenses history runs 7 years deep, the most recent figure standing at $5.0 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 7.64% year-over-year to $5.0 million in Q1 2026; TTM through Mar 2026 was $23.7 million, a 21.76% increase from a year earlier, with the FY2025 full-year figure at $24.1 million, up 30.88% from the prior year.
  • Operating Expenses fell to $5.0 million in Q1 2026 per LGVN's latest filing, from $5.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $7.4 million in Q3 2025 and bottomed at $3.6 million in Q1 2022.
  • The 5-year median for Operating Expenses is $5.2 million (2023), against an average of $5.1 million.
  • Across the five-year window, Operating Expenses slumped 33.78% in 2024 and soared 44.2% in 2025, its largest moves.
  • Year by year, Operating Expenses stood at $5.2 million in 2022, then advanced by 4.86% to $5.4 million in 2023, then fell by 11.53% to $4.8 million in 2024, then gained by 17.56% to $5.7 million in 2025, then retreated by 10.91% to $5.0 million in 2026.
  • Per Business Quant, the three latest LGVN Operating Expenses figures stand at $5.0 million (Q1 2026), $5.7 million (Q4 2025), and $7.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -28.01 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.10 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.85 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -919.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 445.22 Mn
10 Longeveron 14.87 Bn 14.86 Bn 264,000.00 5.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.04 Mn
Dec 31, 2025 5.66 Mn
Sep 30, 2025 7.44 Mn
Jun 30, 2025 5.54 Mn
Mar 31, 2025 5.46 Mn
Dec 31, 2024 4.81 Mn
Sep 30, 2024 5.33 Mn
Jun 30, 2024 3.84 Mn
Mar 31, 2024 4.42 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 5.22 Mn
Jun 30, 2023 5.81 Mn
Mar 31, 2023 4.79 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 5.28 Mn
Jun 30, 2022 4.38 Mn
Mar 31, 2022 3.56 Mn
Dec 31, 2021 4.10 Mn
Sep 30, 2021 5.07 Mn
Jun 30, 2021 5.27 Mn